Liquid biopsies and tumor mutational burden: the cutoff conundrum

被引：2
|
作者：
Kasi, Pashtoon Murtaza [1 ]
机构：
[1] Weill Cornell Med, Meyer Canc Ctr, Englander Inst Precis Med, New York, NY 10021 USA
来源：
NATURE MEDICINE | 2022年 / 28卷 / 09期
关键词：
D O I：
10.1038/s41591-022-01999-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Assessment of tumor mutational burden through a simple blood test could help to identify which patients are most likely to benefit from immunotherapy, but optimal cutoffs are not well established.
引用
收藏
页码：1753 / 1754
页数：2
相关论文
共 50 条
  • [31] Tumor mutational burden on cytological samples: A pilot study
    Pepe, Francesco
    Pisapia, Pasquale
    Gristina, Valerio
    Rocco, Danilo
    Micheli, Mariacarolina
    Micheli, Pietro
    Iaccarino, Antonino
    Tufano, Rossella
    Gragnano, Gianluca
    Russo, Gianluca
    De Luca, Caterina
    Sgariglia, Roberta
    Nacchio, Mariantonia
    Girolami, Ilaria
    Eccher, Albino
    Russo, Antonio
    Troncone, Giancarlo
    Malapelle, Umberto
    CANCER CYTOPATHOLOGY, 2021, 129 (06) : 460 - 467
  • [32] Lung Cancer with a High Tumor Mutational Burden REPLY
    Gandhi, Leena
    Garassino, Marina C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11):
  • [33] Effect of prior therapy on tumor mutational burden in NSCLC
    Jonna, Sushma
    Vanderwalde, Ari
    Nieva, Jorge
    Poorman, Kelsey Anne
    Saul, Michelle
    von Buttlar, Xinyu
    Hu, John Y.
    Liu, Stephen, V
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1231 - 1238
  • [34] Tumor mutational burden: Guidelines for derivation and robustness of measurement
    Mola, Natalie
    Schu, Matthew
    Stiegelmeyer, Suzy
    Jones, Wendell
    Weigman, Victor J.
    CANCER RESEARCH, 2018, 78 (13)
  • [35] The value of tumor mutational burden to select patients for immunotherapy
    Wagener-Ryczek, Svenja
    Buettner, Reinhard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (01) : 1 - 3
  • [36] Genomic Alterations and Tumor Mutational Burden in Melanoma Subtypes
    Carlson, J. Andrew
    Jones, David M.
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti H.
    Fabrizio, David
    Frampton, Garrett
    Ali, Siraj M.
    Schrock, Alexa
    Miller, Vincent
    Stephens, Philip
    Gay, Laurie M.
    Ross, Jeffrey
    MODERN PATHOLOGY, 2017, 30 : 127A - 127A
  • [37] Demystifying the Role of Tumor Mutational Burden for Immunotherapy Selection
    Fabrizio, David A.
    Hegde, Priti
    Alexander, Brian
    JAMA ONCOLOGY, 2020, 6 (11) : 1808 - 1809
  • [38] Genomic Alterations and Tumor Mutational Burden in Melanoma Subtypes
    Carlson, J. Andrew
    Jones, David M.
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti H.
    Fabrizio, David
    Frampton, Garrett
    Ali, Siraj M.
    Schrock, Alexa
    Miller, Vincent
    Stephens, Philip
    Gay, Laurie M.
    Ross, Jeffrey
    LABORATORY INVESTIGATION, 2017, 97 : 127A - 127A
  • [39] Tumor mutational burden as predictive factor of response to immunotherapy
    Gonzalez-Cao, Maria
    Viteri, Santiago
    Karachaliou, Niki
    Aguilar, Andres
    Jose Garcia-Mosquera, Juan
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S358 - S361
  • [40] Tumor mutational burden in colorectal cancer: Implications for treatment
    Marques, Adriana
    Cavaco, Patricia
    Torre, Carla
    Sepodes, Bruno
    Rocha, Joao
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 197
12345